|
The latest Mainline newsletters for the General Public are listed here. |
For healthcare professionals we have a Mainline newsletter in a Professional version here. |
Mainline |
||
| Volume 2 | November 11, 2005 | Number82 |
An Exclusive Continuing Education Publication of Acadiana Consultant Pharmacy Service |
||
Medication News & Update
Eli Lilly has infomed the FDA that its ads for Cymbalta which promote its use for neuropathic pain will no longer run. FDA criticized the drug company because it had failed to clearly state the risk associated with the use of Cymbalta. There is a risk of dementia when used with MAOIs.
 |
|
[ Home ]
[ About Us ]
[ Assessment Tools ]
[ Sample Consult ] |
